Technologies Inc. (NYSE: A) today announced a range of new products
designed to deliver improved analytical and business outcomes for
laboratories involved in a variety of analytical pursuits, including
food testing, environmental screening, and metabolomics research.
The centerpiece of the announcement—the new Agilent 6546 quadrupole
time-of-flight LC/MS system—gives analysts the ability to acquire
high-resolution data across an unprecedented dynamic range. This
innovative instrument includes the Q-RAI (Quadrupole-Resolved All Ions),
a data-independent acquisition mode which reduces the complexity of
MS/MS spectra while maximizing the accuracy and quality of the data
“The Agilent 6546 LC/Q-TOF is a major advancement compared to previous
time-of-flight systems because it combines dynamic range with excellent
resolution in all conditions (speed, mass range, intensity),” said
Nicola Zamboni, head of the Swiss Federal Institute of Technology in
Zurich. “In our lab, the 6546 will be a great instrument for challenging
applications such as 13C metabolic flux analysis, high-throughput mass
spectrometry, and metabolite identification.”
MassHunter software complementing the Agilent 6546 LC/Q-TOF includes:
MassHunter Quantitative Analysis 10.0 software with new features that
allow labs to more quickly and accurately screen complex sample sets
for both target and suspect compounds in a single workflow—ideal for
food safety, and environmental analysis.
New MassHunter Classifier software which complements the enhanced
method development workflow in the Mass Profiler Professional (MPP)
software, enabling faster testing for food authenticity with results
that are easier to review.
MassHunter Lipid Annotator that presents theoretical lipid MS/MS
annotations for Q-TOF results with support through the MassHunter Mass
Profiler Professional Lipidomics workflow.
Agilent also announced the new Agilent Bravo Metabolomics Sample Prep
Platform—the perfect partner for the Agilent 6546 LC/Q-TOF—which
provides consistent and accurate preparation of human plasma samples for
metabolomics analysis via LC/MS.
“Together, these new products will enable laboratories to spend less
time getting the answers they need—and increase the confidence they have
in their results,” said Monty Benefiel, Agilent vice president, and
general manager of the company’s Mass Spectrometry Division.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences,
diagnostics, and applied chemical markets. Based on more than 50 years
of insight and innovation, Agilent instruments, software, services,
solutions, and people provide trusted answers to customers’ most
challenging questions. The company generated revenues of $4.91 billion
in fiscal 2018 and employs 15,300 people worldwide. Information about
Agilent is available at www.agilent.com.
To receive the latest Agilent news, subscribe to our Newsroom.
Follow Agilent on LinkedIn,